New Tech Qualifying Criteria Should Incorporate Value – MedPAC Staffers
This article was originally published in The Gray Sheet
Executive Summary
Policymakers should seek to integrate "value-based purchasing" in determining whether to pay for new technologies, according to a Health Affairs article
You may also be interested in...
Imaging, Cardiac Care Linked To Rising Healthcare Costs – BlueCross Study
Escalating MRI use does not reduce total utilization of CT scans and other imaging modalities, suggesting that increased availability is associated with uptake of other imaging services, according to a Health Affairs study
DME Competitive Bidding, New Tech Payments To Be Taken Up By Conferees
A provision establishing clinical trial coverage for Category A devices is part of a larger consensus reached by conferees on less controversial aspects of the "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1, S 1)
First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)